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follow-up experiments that would provide
evidence for or against a particular hypoth-
esis. The authors deserve credit for enthusi-
astically tackling complex and often
awkward aspects of human biology and for
writing in an accessible style. Unfortunately,
though, they take their title too literally and
their “just-so stories” end up being as de-
fined: delightful, but empty.
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Ethics and Newborn Genetic Screening
addresses the ethical and policy issues sur-
rounding technological advances that have
allowedroutinetestingfordozensofraredis-
eases. This book describes newborn screen-
ingprogramswithanhistoricalarc,depicting
whatisatitsrootaclassiccaseoftechnology
outpacing self-reflection. The arc covers
everything from the original controversial
screeningprogramforphenylketonuriatothe
modern ease of checking as many boxes as
one wishes without adding any considerable
cost or effort. It is sometimes taken for
granted that more testing is better, but this
bookmakesacaseforrationaltesting,outlin-
ing reasons and practical methods to make it
happen at a national level.
The book is a compilation of essays by a
wide variety of experts. Each is concerned
with a very different aspect of newborn
screening.Thevarietyofperspectivesweaves
astorythatiscomplexandsometimescontra-
dictory, but always thought provoking. Some
particularly fascinating chapters are dense
overviewsofentireschoolsofthought,almost
self-contained primers on public health.
A chapter by editor Mary Ann Baily in-
terweaves the issue of fair distribution of test-
ing burdens and benefits with that of
healthcaredistributioningeneral.Thisexposes
one of many odd paradoxes of our healthcare
system:ourwillingnesstospendstateandfed-
eralmoneytotestforconditionsthatourfrag-
mentedsystemwilllaterallowtogountreated.
Our affection for newborns apparently does
not extend to the resulting adults.
Scott Grosse writes a terrific overview
of cost-effectiveness analysis, using exam-
ples of newborn genetic screening as a vehi-
cle to explain this frequently used tool. His
views are balanced by a firsthand perspec-
tive from an advocate for genetic screening,
who is both a concerned mother and geneti-
cist.This could be the most valuable chapter
for those of us with a scientific background,
as her reasoning is rational yet sometimes
contrary to the traditional criteria for good
screening tests.
The opening and closing chapters by the
editors provide the rationale for the compila-
tion,framingthegeneralissuetobediscussed.
The theoretical framework complements
many of the chapters with narrower, more
concretesubjectmatter.Overall,thebookisa
well-assembledtreatmentofnewbornscreen-
ing, sure to spark discussion in medical and
bioethical communities.
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Immunology: Clinical Case Studies and
Disease Pathophysiology is a well-written
transcript that underscores the importance of
understanding basic immunology to transla-
tional modern medicine. Using 26 in-depth
case studies, the reader is familiarized with
immunodeficiency diseases, autoimmunity
disorders, malignancies and immediate hy-
persensitivity, and mast cell disorders. Each
case study is presented in a detailed im-
munological background supported by real
data and handy references. The problem set